PRIVATE FOA: Damon Runyon Cancer Research Foundation Invites Applications for Physician-Scientist Training Award [K08 or K23]

Damon Runyon Cancer Research Foundation Invites Applications for Physician-Scientist Training Award

A scientist holding a Petri Dish with Virus and bacteria cells.
SOURCE: Damon Runyon Cancer Research Foundation
APPLICATION DEADLINE: 12/1/15.
$ AVAILABLE: The award will provide up to $460,000 in financial support over four years. In addition, the foundation will retire up to $100,000 of any outstanding medical school debt owed by a grant recipient.
ELIGIBILITY: To be eligible, physician-scientist applicants (MDs only) must have completed their residencies and clinical training, be U.S. specialty board-eligible prior to the award start date, have not had more than three years of postdoctoral laboratory research experience, and be able to devote at least 80 percent of their time and effort to DRCRF-supported research. Awardees may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source or federal government (e.g., K08 or K23) may be held concurrently with this award.
PURPOSE: The Damon Runyon Cancer Research Foundation is accepting applications for its 2016 Physician-Scientist Award.
The annual program provides physicians who wish to pursue a career in cancer research with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed their clinical training.
The goals of the program are to transform these talented individuals into the highest quality physician-scientists capable of conducting research that has the potential to transform the diagnosis, treatment, and/or prevention of cancer; and to eliminate the financial disincentive to entering this career path.
CONTACT: Award Programs, (212) 455-0520, email: awards@damonrunyon.org. For more information see: http://www.damonrunyon.org/for_scientists/more/physician_scientist_training_award_overview
From The Foundation Center’s Philanthropy News Digest web site, accessed 10/22/15icon
Subject(s) cancer research, health professions training

PRIVATE FOA: AONE Foundation for Nursing Leadership and Education Accepting Applications for Small Grants

AONE Foundation for Nursing Leadership and Education Accepting Applications for Small Grants

Portrait of a doctor with two of her co-workers talking with a patient in the background

SOURCE: AONE Foundation for Nursing Leadership and Education
APPLICATION DEADLINE: 12/31/15.
$ AVAILABLE: In 2016, grants of up to $10,000 will be awarded in support of projects that advance innovation as a core competency for all nurse leaders; promote community-based teams across the care continuum; encourage provision of safe, quality care in delivery systems grounded in healthful practice environments; and improve communication of the value of nursing in healthcare to all stakeholders.
ELIGIBILITY: AONE members and nonmembers alike are eligible.
PURPOSE: The AONE Foundation for Nursing Leadership Research and Education was established in 2010 to support the research and educational priorities of the American Organization of Nurse Executives, a national membership organization for nurses who design, facilitate, and manage care. Since 1967, AONE has provided leadership, professional development, advocacy, and research to advance nursing practice and patient care, promote nursing leadership excellence, and to shape public policy for health care.
The foundation is accepting applications for its Small Grants Program, which supports research projects that align with its research priorities.
CONTACT: M.T. Meadows, (312) 422-2807, email: mmeadows@aha.org.

For more information see http://www.aone.org/aone_foundation/smallgrants.shtml
From The Foundation Center’s Philanthropy News Digest web site, accessed 10/22/15icon
Subject(s) medical research, nursing

PRIVATE FOA: American Heart Association Hypertension Control Grants

American Heart Association Hypertension Control Grantshypertension
SOURCE: American Heart Association (AHA) SouthWest Affiliate
APPLICATION DEADLINE: 11/3/15 at 4 pm CST.
$ AVAILABLE: The maximum amount for an individual grant is $100,000.
ELIGIBILITY: Nonprofit healthcare entities in Arkansas, Colorado, New Mexico, Oklahoma, Texas, and Wyoming.
PURPOSE: There are 80 million adults (1 in 3 Americans) living with high blood pressure. Despite improved access to care, effective therapies, and proven lifestyle interventions, achieving success in hypertension control remains an increasing challenge. Nearly 46 percent (36.7 million) of adults with high blood pressure are not controlled to goal. In November 2013, the AHA, American College of Cardiology and Centers for Disease Control jointly published a new science advisory that urged doctors, other healthcare providers and hospitals to collaborate on programs that help patients control high blood pressure.
AHA set forth an aggressive goal to move 13.6 million Americans to control their high blood pressure by 2020. The Board of Directors for the SouthWest Affiliate has made hypertension control a priority and is demonstrating its commitment by making $500,000 available in funding.
This RFP [Request for proposals] serves as a catalyst for institutions to make hypertension a priority by adopting guidelines and a team-base care approach to improve performance measures around hypertension management. The target goal for this request for proposal is for the healthcare systems to drive a minimum hypertension control rate of 70 percent and the healthcare system which achieves the highest control rate will receive an additional $10,000 bonus award.
CONTACT: Brion Oaks, (512) 338-2478, email: brion.oaks@heart.org.

Go to: https://www.surveymonkey.com/r/CheckChangeControl for the on-line application.
From American Heart Association SouthWest Affiliate email, 10/21/15icon
Subject(s) cardiovascular/heart disease, medical research

PRIVATE FOA: American Head and Neck Society Accepting LOIs for Pilot Program Grants

American Head and Neck Society Accepting LOIs for Pilot Program GrantsENT_illustration_small
SOURCE: American Head and Neck Society
APPLICATION DEADLINE: Letters of Intent: 12/15/15.
$ AVAILABLE: Grants of up to $10,000.
ELIGIBILITY: To be eligible, applicants must reside in the United States or Canada and be a medical student, resident, Ph.D., or faculty member at the rank of associate professor or below.
PURPOSE: The American Head and Neck Society is accepting Letters of Intent to its Pilot Grants program.
Grants will be awarded in support of basic, translational, or clinical research projects in head and neck oncology. Clinical or translational research studies are strongly encouraged and should be specifically related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck neoplastic disease.
CONTACT: Cynthia Zarate, email: Cynthia@ahns.info.

For more information see:

http://www.entnet.org/sites/default/files/uploads/PracticeManagement/Research/_files/2016-ahns-pilot-research-foa.pdf
From The Foundation Center’s Philanthropy News Digest web site, accessed 10/22/15
Subject(s) cancer research

PRIVATE FOA: American College Health Foundation Seeks Applications for Student Mental Health Award

American College Health Foundation Seeks Applications for Student Mental Health AwardMentalHealth-s
SOURCE: American College Health Foundation
APPLICATION DEADLINE: 1/31/16.
$ AVAILABLE: A single grant of up to $2,500.
ELIGIBILITY: To be eligible, applicants must be a full-time undergraduate or graduate student enrolled at an American College Health Association (ACHA) member institution. Preference will be given to graduate students engaged in mental health professional training programs.
PURPOSE:

The American College Health Foundation is seeking applications for its 2016 Stephan D. Weiss Mental Health Award.
Through the annual program, which is sponsored by the Stephan D. Weiss Foundation and the Weiss Fund, a single grant will be awarded to support a student’s efforts to promote and improve the quality of mental health care available to college students. The Weiss Award is intended to encourage the development of creative initiatives that will enhance mental health service delivery to students and which can be replicated at other colleges or universities. The award will support programs that can demonstrate measurable success in student retention for those whose mental health problems might otherwise compromise the quality of their college experience and jeopardize their ability to graduate.
CONTACT: Marthea J. Proudfoot, (410) 914-5575, email: mproudfoot@acha.org.

For more information see http://www.acha.org/ACHA/Foundation/Weiss_Award.aspx
From The Foundation Center’s Philanthropy News Digest web site, accessed 10/22/15icon
Subject(s) health professions training, mental health

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01): RFA-FD-15-001
SOURCE: U.S. Food and Drug Administration (FDA), Office of Orphan Products Development (OPD)
APPLICATION DEADLINE: 2/3/16, 2/1/17, 2/7/18.
$ AVAILABLE: $14.1 million in FY2016, FY2017, FY2018, and FY2019.

orphan-drugs-acts-past-and-current-scenario-with-upcoming-drugs-20-638
Background

The OPD was created to identify and promote the development of orphan products. Orphan products are drugs, biologics, medical devices, and medical foods that are indicated for a rare disease or condition. The term “rare disease or condition” is defined in 21 U.S.C. 360ee.  As a practical way to implement the statutory definition, for devices and foods as well as for drugs, FDA considers drugs, devices, and medical foods potentially eligible for grants under the OPD grant program if they are indicated for a disease or condition that has a prevalence, not incidence, of fewer than 200,000 people in the United States. Diagnostics and vaccines are considered potentially eligible for such grants only if the U.S. population to whom they will be administered is fewer than 200,000 people in the United States per year.

Research Objectives

The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application’s Background and Significance section documentation to support that the estimated prevalence of the orphan disease or condition in the United States is less than 200,000 (or in the case of a vaccine or diagnostic, information to support that the product will be administered to fewer than 200,000 people in the United States per year),and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.  Additional information may be required upon request, for example, regarding population estimate and rationale.  This additional information may be required, in part, to assure that human clinical trials of drugs are eligible to receive funding under the OPD grant program.  21 U.S.C. 360ee(b)(1)(A).See Section VIII, Other Information – Required Federal Citations, for policies related to this announcement.

– See more at: http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-001.html#sthash.KSPsucAw.dpuf
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy.
CFDA: 93.103
CONTACT: Please see URL for multiple contacts.

For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-001.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 10/21/15icon
Subject(s) medical research, minority health

Adaptation/Optimization of Technology (ADOPTech) to Support Social Functioning (R21)

RFA-MH-17-150

Adaptation/Optimization of Technology (ADOPTech) to Support Social Functioning (R21)
Department of Health and Human Services
National Institutes of Health

download

A R21 Grant is an Exploratory/Developmental Research Grant

Research Strategy: Applications should discuss how the technology will produce a measureable impact on a key aspect of social functioning (e.g., social communication, perception and understanding of self or others, etc.) rather than increasing or improving a discrete behavior (e.g., eye contact). In addition, applications must discuss how the novel technology would eventually be translated into mainstream or everyday contexts (e.g., the feasibility of fully customized technologies vs. commercially available products which have been augmented for specialized use). Applications that do not address how the novel technology will be translated into mainstream contexts will be considered incomplete.

Finally, when such features are relevant, applications should address test-retest reliability, optimal duration or length of measurement, scalability of the technology, and use of indicators or metrics to determine accuracy, thresholds, and/or fidelity.

Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide, with the following modification:

All applications, regardless of the amount of direct costs requested for any one year, should address a Data Sharing Plan. The National Institute of Mental Health (NIMH) has established an informatics infrastructure to enable the sharing and use of data collected from human subjects in clinical research by the entire research community. Researchers funded by this FOA are expected to deposit data from human subjects into this infrastructure. Please refer to NOT-MH-15-012 for details regarding the available data repositories.

Appendix:  Do not use the Appendix to circumvent page limits. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.

For more information on a SF424 please see the example under the Grant Writing tab above.

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-MH-17-150
Funding Opportunity Title: Adaptation/Optimization of Technology (ADOPTech) to Support Social Functioning (R21)
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Posted Date: Oct 22, 2015
Creation Date: Oct 22, 2015
Original Closing Date for Applications: Feb 3, 2016  
Current Closing Date for Applications: Feb 3, 2016  
Archive Date: Mar 5, 2016
Estimated Total Program Funding: $2,500,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants:
Private institutions of higher education
For profit organizations other than small businesses
City or township governments
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Small businesses
County governments
State governments
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the development and testing of new, cutting-edge technologies to enhance functioning in individuals with social impairments. Projects funded under this FOA would create social prosthetics: scalable technology or devices that would augment performance in this domain.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-17-150.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster